CBD offers hope for kids with Hard-to-Treat seizures
NCT ID NCT02556008
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study gives cannabidiol (CBD) to 25 children aged 1 to 17 with severe epilepsy that hasn't improved with other treatments. The goal is to see if CBD can reduce seizure frequency. Children will be monitored before and after starting CBD, which is added to their current epilepsy medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cannabidiol (CBD)
- What this could lead to
- If it works, this could provide a treatment option for children with severe epilepsy who have not been helped by other medications.
- What could go wrong
- This is an early, small study with only 25 children, and CBD is not yet FDA-approved. It may not work for everyone, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY CHILDHOOD EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, Los Angeles
Los Angeles, California, 90095, United States